Shanghai MicuRx advances MRX-4 trial results towards NDA approval

Shanghai MicuRx Pharmaceutical Co., Ltd. has announced a major breakthrough in antibacterial drug development, successfully completing its Phase III clinical trial of MRX-4 for injection ... Read More